Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Summary
GlobalData’s medical equipment report, “Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the global coronary stents market, a key segment within cardiovascular devices. The report provides market landscape, competitive landscape and market trends information the coronary stents market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
GlobalData’s medical equipment report, “Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the global coronary stents market, a key segment within cardiovascular devices. The report provides market landscape, competitive landscape and market trends information the coronary stents market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Bare Metal Stents (BMS) and Drug Eluting Stents (DES).
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the coronary stents market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Cordis, Boston Scientific Corporation, Medtronic and Abbott.
- Develop business strategies by understanding the trends and developments that are driving the coronary stents market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the coronary stents market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global coronary stents market and the factors shaping it.
Contents
1 TABLE OF CONTENTS1.1 List of Tables
1.2 List of Figures
2 INTRODUCTION: CORONARY STENTS
2.1 GlobalData Report Guidance
3 DISEASE OVERVIEW: CORONARY HEART DISEASE (CHD)
3.1 Pathophysiology
3.2 Signs and Symptoms
3.3 Risk Factor
3.3.1 Major Risk Factors that can’t be Altered
3.3.2 Major Risk Factors that can be Altered
3.3.3 Other Risk Factors
3.4 Diagnosis
3.4.1 Electrocardiogram (ECG or EKG):
3.4.2 Exercise thallium test:
3.4.3 Echocardiography:
3.4.4 Coronary angiography:
3.4.5 Positron Emission Tomography (PET scanning):
3.5 Treatment
3.5.1 Coronary Heart Disease Epidemiology
3.5.2 Treatment modalities for CHD
4 GLOBAL CORONARY STENTS MARKET CHARACTERIZATION
4.1 Global Coronary Stents Market, Revenues ($bn), Historic, 2002 – 2009
4.2 Global Coronary Stents Market, Revenues ($bn), Forecast, 2009 – 2016
4.3 Global Coronary Stents, Market Dynamics
4.3.1 Coronary Stents: Market Drivers
4.3.2 Coronary Stents: Market Restraints
5 GLOBAL CORONARY STENTS MARKET: SEGMENT ANALYSIS
5.1 Bare Metal Stents, Global, Revenue ($bn), Historic, 2002– 2009
5.1.1 Bare Metal Stents, Global, Revenue ($bn), Forecast, 2009– 2016
5.2 Global Bare Metal Stents: Market Dynamics
5.2.1 Bare Metal Stents: Market Drivers
5.2.2 Bare Metal Stents: Market Restraints
5.2.3 Drug Eluting Stents, Global, Revenue ($bn), Historic, 2002– 2009
5.2.4 Drug Eluting Stents, Global, Revenue ($bn), Forecast, 2009– 2016.
5.3 Global Drug Eluting Stents:Market Dynamics
5.3.1 Drug Eluting Stents: Market Drivers
5.3.2 Drug Eluting Stents: Market Restraints
6 THE GLOBAL CORONARY STENTS MARKET: CROSS COUNTRY ANALYSIS AND FORECASTS
6.1 Revenue and Revenue Forecast, By Country
6.1.1 US Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.2 US Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
6.1.3 Canada Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.4 Canada, Coronary Stents market, Revenue ($ m), Forecast, 2002-2009
6.1.5 UK Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.6 UK Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
6.1.7 Italy, Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.8 Germany, Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.9 Germany, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
6.1.10 France, Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.11 France, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
6.1.12 Spain, Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.13 Spain, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
6.1.14 Japan, Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.15 Japan, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
6.1.16 China, Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.17 China, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
6.1.18 India, Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.19 India, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
6.1.20 Brazil, Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.21 Brazil, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
6.1.22 Australia, Coronary Stents market, Revenue ($ m), Historic, 2002-2009
6.1.23 Australia, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016
7 GLOBAL CORONARY STENTS MARKET: STRATEGIC COMPETITIVE ASSESMENT
7.1 Boston Scientific Corporation
7.1.1 Overview:
7.2 Cordis Corporation
7.2.1 Overview
7.3 Abbott Laboratories
7.3.1 Overview
7.4 Medtronic, Inc.
7.4.1 Overview
8 GLOBAL CORONARY STENTS MARKET, KEY MARKETED PRODUCTS
8.1 Key Coronary Stents in the Market
8.1.1 CYPHER sirolimus-eluting coronary stents (JNJ Cordis)
8.1.2 PROMUS (Boston Scientific)
8.1.3 ENDEAVOR (Medtronic)
8.1.4 TAXUS Express2 (Boston Scientific)
8.1.5 TAXUS Liberte (Boston Scientific)
8.1.6 TriMaxx Coronary Stent (Abbott)
8.1.7 MULTI-LINK FRONTIER Coronary Bifurcation Stent System (Abbott)
9 GLOBAL CORONARY STENTS MARKET: STRATEGIC PIPELINE ASSESSMENT
9.1 Pipeline Technology Assessment
9.1.1 Pipeline Technology Assessment for Coronary Stents by Development Stage, Global
9.1.2 Emerging Technologies in the Coronary Stent Market
9.2 Profiles of Promising Products Under Clinical Development:
9.2.1 BioMatrix Drug Eluting Stent (Biosensors)
9.2.2 NEVO Sirolimus-eluting Coronary Stent (Cordis)
9.2.3 PROTEX Coronary Stent System (Nexeon MedSystems)
9.2.4 Valecor Platinum Coronary Stent System (CorNova)
9.2.5 GTX Coronary Stent System (Cook Medical)
9.2.6 JST Drug-Eluting Stent (Japan Stent Technology)
9.2.7 ProGenic Pimecrolimus-eluting Coronary Stent System (BIOTRONIK SE & Co. KG)
9.2.8 MAHOROBA (KANEKA CORPORATION)
9.2.9 ProLink LP (Vascular Concepts Limited)
9.2.10 ChromoFlex Coronary Stent (DISA Vascular)
9.2.11 Next generation everolimus-based stent (Boston Scientific)
9.2.12 ProNova Sirolimus Eluting Stent (Vascular Concepts Limited)
9.2.13 Coroflex DEBlue (B. Braun Melsungen AG)
9.2.14 Endeavor Resolute (Medtronic)
9.2.15 XIENCE NANO (Abbott Vascular)
9.2.16 TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System (Boston Scientific)
9.2.17 CYPHER Max (4.0) (RX) (Cordis Corporation)
9.3 Coronary Stents:List of Pipeline Products
10 GLOBAL CORONARY STENTS MARKET: KEY COMPANIES WITH PRODUCTS IN CLINICAL DEVELOPMENT
10.1.1 Biosensors International Group, Ltd.
10.1.2 Cook Medical Incorporated
10.1.3 OrbusNeich
10.1.4 Vascular Concepts Limited
10.1.5 CorNova, Inc.
10.1.6 Nexeon MedSystems, Inc.
11 GLOBAL CORONARY STENTS MARKET: STRATEGIC DEALS ANALYSIS
11.1 Key Acquisitions
11.1.1 Medtronic Completes Acquisition Of Invatec And Affiliated Companies
11.1.2 Boston Scientific Acquires Labcoat
11.1.3 Bayer MaterialScience Completes Acquisition Of PolyBioMed From Lombard Medical Technologies
12 APPENDIX
12.1 Definitions
12.1.1 Coronary Stents
12.2 Acronyms
12.3 Research Methodology
12.4 Secondary Research
12.5 Primary Research
12.6 Models
12.7 Forecasts
12.8 Expert Panels
12.9 GlobalData Consulting
12.10 Contact Us
12.11 Disclaimer
LIST OF TABLES
Table 1: Coronary Stents Market, Global, Revenue ($bn), 2002 – 2009
Table 2: Coronary Stents Market, Global, Revenue ($bn), 2009 – 2016
Table 3: Bare Metal Stents, Global, Revenue ($bn), 2002– 2009
Table 4: Bare Metal Stents, Global, Revenue ($bn), 2009–2016
Table 5: Drug Eluting Stents Market, Global, Revenue ($bn), 2002– 2009
Table 6: Drug Eluting Stents, Global, Revenue ($bn), 2009– 2016
Table 7: Coronary Stents Market, Cross Country Analysis, Revenue ($m) and CAGR (%), 2002-2016
Table 8: Coronary Stents Market, US, Revenue ($ m), 2002-2009
Table 9: Coronary Stents Market, US, Revenue ($ m), 2009-2016
Table 10:Coronary Stents Market, Canada, Revenue ($ m), 2002-2009
Table 11:Coronary Stents Market, Canada, Revenue ($ m), 2009-2016
Table 12: Coronary Stents Market, UK, Revenue ($ m), 2002-2009
Table 13: Coronary Stents Market, UK, Revenue ($ m), 2009-2016
Table 14: Coronary Stents Market, Italy, Revenue ($ m), 2002-2009
Table 15: Coronary Stents Market, Italy, Revenue ($ m), 2009-2016
Table 16: Coronary Stents Market, Germany, Revenue ($ m), 2002-2009
Table 17: Coronary Stents Market, Germany, Revenue ($ m), 2009-2016
Table 18: Coronary Stents Market, France, Revenue ($ m), 2002-2009
Table 19: Coronary Stents Market, France, Revenue ($ m), 2009-2016
Table 20: Coronary Stents Market, Spain, Revenue ($ m), 2002-2009
Table 21: Coronary Stents Market, Spain, Revenue ($ m), 2009-2016
Table 22: Coronary Stents Market, Japan, Revenue ($ m), 2002-2009
Table 23: Coronary Stents Market, Japan, Revenue ($ m), 2009-2016
Table 24: Coronary Stents Market,China, Revenue ($ m), 2002-2009
Table 25: Coronary Stents Market,China, Revenue ($ m), 2009-2016
Table 26: Coronary Stents Market, India, Revenue ($ m), 2002-2009
Table 27: Coronary Stents Market, India, Revenue ($ m), 2009-2016
Table 28: Coronary Stents Market, Brazil, Revenue ($ m), 2002-2009
Table 29: Coronary Stents Market, Brazil, Revenue ($ m), 2009-2016
Table 30: Coronary Stents Market, Australia, Revenue ($ m), 2002-2009
Table 31: Coronary Stents Market, Australia, Revenue ($ m), 2009-2016
Table 32: Drug Eluting Stents Market , Global, Company Shares Revenue ($m), 2009
Table 33: Bare Metal Stents Market, Global, Company Shares Revenue ($m), 2009
Table 34: Boston Scientific Corporation, Coronary Stents, Pipeline Products
Table 35: Cordis, Coronary Stents, Pipeline Products
Table 36: Abbott Coronary Stents Pipeline Products
Table 37: Medtronic Coronary Stents Pipeline Products
Table 38: Current Drug-Eluting Stents Approved for Use in the US
Table 39: CYPHER Coronary Stent
Table 40: CYPHER (SIRIUS Pivotal Trial)
Table 41: CYPHER (RAVEL Supporting Trial)
Table 42: PROMUS Coronary Stent
Table 43: PROMUS (SPIRIT III Trial))
Table 44: ENDEAVOR Coronary Stent
Table 45: ENDEAVOR (ENDEAVOR III Trial))
Table 46: ENDEAVOR (ENDEAVOR IV Trial))
Table 47: TAXUS Express2 (TAXUS IV Trial))
Table 48: TAXUS Liberte (ATLAS Trial))
Table 49: Biomatrix III (LEADER Trial)
Table 50: Biomatrix (STEALTH)
Table 51: NEVO Sirolimus-eluting coronary stent (RES-ELUTION II)
Table 52: NEVO Sirolimus-eluting coronary stent (RES-ELUTION I): Pivotal trial
Table 53: GTX Coronary Stent System
Table 54: ProGenic Pimecrolimus-eluting Coronary Stent System
Table 55: MAHOROBA
Table 56: ProLink LP
Table 57: ChromoFlex Coronary Stent
Table 58: ProNova Sirolimus Eluting Stent
Table 59: Coroflex DEBlue (PEPCADIIIsub)
Table 60: ENDEAVOR Resolute
Table 61: TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System
Table 62: Coronary Stents : Pipeline Summary
Table 63: Biosensors International Group Pipeline Products
Table 64: Cook Medical Pipeline Products
Table 65: OrbusNeich Pipeline Products
Table 66: Vascular Concepts Limited Pipeline Products
Table 67: CorNova, Inc Pipeline
Table 68: Nexeon MedSystems, Inc Pipeline Products
Table 69: Coronary Stents: Key Acquisitions
LIST OF FIGURES
Figure 1: Signs and Symptoms of Coronary Heart Disease
Figure 2: Treatment Flow Model, Coronary Stents for Treatment of Coronary Heart Disease, US, 2009
Figure 3: Treatment Flow Model, Coronary Stents for Treatment of Coronary Heart Disease, Europe, 2009
Figure 4: Treatment Modalities for Coronary Heart Disease, 2009
Figure 5: Coronary Stents Market, Global, Revenue ($bn), 2002 – 2009
Figure 6: Coronary Stents Market, Global, Revenue ($bn), 2009 – 2016
Figure 7: Drivers and Restraints in the Coronary Stents Market
Figure 8: US, Breakdown of Deaths from Cardiovascular Diseases, %,2006
Figure 9 Bare Metal Stents Market, Global, Revenue ($bn), 2002– 2009
Figure 10: Bare Metal Stents Market, Global, Revenue ($bn), 2009–2016
Figure 11: Drug Eluting Stents Market, Global, Revenue ($bn), 2002–2009
Figure 12: Drug Eluting Stents Market, Global, Revenue ($bn), 2009– 2016
Figure 13: Coronary Stents Market, Cross Country Analysis, Global, Revenue and growth Comparison 2002-2016
Figure 14: Coronary Stents Market, US, Revenue ($ m), 2002-2009
Figure 15: Coronary Stents Market, US, Revenue ($ m), 2009-2016
Figure 16: Coronary Stents Market, Canada, Revenue ($ m), 2002-2009
Figure 17: Coronary Stents Market, Canada, Revenue ($ m), 2009-2016
Figure 18: Coronary Stents Market, UK, Revenue ($ m), 2002-2009
Figure 19: Coronary Stents Market, UK, Revenue ($ m), 2009-2016
Figure 20: Coronary Stents Market, Italy, Revenue ($ m), 2002-2009
Figure 21: Coronary Stents Market, Italy, Revenue ($ m), 2009-2016
Figure 22: Coronary Stents Market, Germany, Revenue ($ m), 2002-2009
Figure 23: Coronary Stents Market, Germany, Revenue ($ m), 2009-2016
Figure 24: Coronary Stents Market, France, Revenue ($ m), 2002-2009
Figure 25: Coronary Stents Market, France, Revenue ($ m), 2009-2016
Figure 26: Coronary Stents Market, Spain, Revenue ($ m), 2002-2009
Figure 27: Coronary Stents Market, Spain, Revenue ($ m), 2009-2016
Figure 28: Coronary Stents Market, Japan, Revenue ($ m), 2002-2009
Figure 29: Coronary Stents Market, Japan, Revenue ($ m), 2009-2016
Figure 30: Coronary Stents Market,China, Revenue ($ m), 2002-2009
Figure 31: Coronary Stents Market, China, Revenue ($ m), 2009-2016
Figure 32: Coronary Stents Market, India, Revenue ($ m), 2002-2009
Figure 33: Coronary Stents Market, India, Revenue ($ m), 2009-2016
Figure 34: Coronary Stents Market, Brazil, Revenue ($ m), 2002-2009
Figure 35: Coronary Stents Market, Brazil, Revenue ($ m), 2009-2016
Figure 36: Coronary Stents Market, Australia, Revenue ($ m), 2002-2009
Figure 37: Coronary Stents Market, Australia, Revenue ($ m), 2009-2016
Figure 38: Drug Eluting Stents Market, Global, Company Share (% of Revenue), 2009
Figure 39: Bare Metal Stents Market, Global, Company Shares (% Revenue), 2009
Figure 40: Pipeline Technology Assessment for Coronary Stents by Development Stage, Global
Figure 41: Pipeline Technology Assessment for Drug Eluting and Bare Metal Stents By Development Stage, Global
Figure 42: Pipeline Technology Assessment for Drug Eluting Stents by Unmet Need, Global
Figure 43: Pipeline Technology Assessment for Bare Metal Stents by Unmet Need, Global
Figure 44: Key Acquisitions in 2009-2010
Figure 45: GlobalData Methodology
COMPANIES MENTIONED
Boston Scientific Corporation
Cordis Corporation
Abbott Laboratories
Medtronic, Inc Skip to top